| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |